Celldex Therapeutics Inc
(FRA:TCE2)
€
33.01
+1.16 (+3.64%)
Market Cap: 2.64 Bil
Enterprise Value: 2.25 Bil
PE Ratio: 0
PB Ratio: 5.60
GF Score: 58/100 Celldex Therapeutics Inc (FRA:TCE2) Transcripts
- 1